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Abstract 
 Heart disease is the leading cause of adult death in the United States.  Chronic ischemia resulting from obstruction of coronary arteries is a major contributor to onset and progression of heart disease.  Hibernating myocardium is a clinical condition in which chronic ischemia results in viable, yet persistently dysfunctional, myocardium.  On a molecular level, the mitochondrial proteome is depressed, contributing to decreased energetic capacity.  Hibernating myocardium is treated by coronary artery bypass graft surgery, restoring normal blood flow to the ischemic region of the heart.  However, CABG results in variable and often incomplete recovery as evidenced by continued physiological and mitochondrial dysfunction.  Oxidative stress and inflammation are believed to play primary roles in continued dysfunction.  As such, we tested the hypothesis that inflammation is increased following CABG, resulting in increased oxidative stress and continued depression of mitochondrial proteins.  In a swine model of revascularized hibernating myocardium, prostaglandin E2 was significantly increased in revascularized hibernating myocardium compared to healthy tissue.  In a cell culture model, H9c2 cells treated with PGE2 exhibited increased production of markers of oxidative stress and decreased expression of mitochondrial electron transport chain proteins, supporting the potential role of inflammation in persistent dysfunction despite successful revascularization of hibernating myocardium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction  Cardiovascular disease is the leading cause of death in America, resulting in 600,000 deaths each year (1). Cardiovascular disease often results from atherosclerosis, in which arteries accumulate plaque. Atherosclerosis results in cardiac ischemia, as constricted arteries fail to deliver blood and oxygen to the heart(2).   Hibernating myocardium results from decreased blood flow, and is characterized by viable, but persistently dysfunctional myocardium. Our current swine model constricts the left anterior descending coronary artery (LAD), causing chronic ischemia. The animal then undergoes coronary artery bypass graft (CABG) surgery to restore blood flow to the myocardium. After one month recovery, the animal is sacrificed and its tissue analyzed for proteins that indicate dysfunction and oxidative stress.   CABG surgery corrects the physiological cause of chronic ischemia.  However, recovery varies and tissue fails to regain full function(3). This may be due to the downregulation of mitochondrial proteins. While this downregulation may protect hibernating myocardium from necrosis prior to revascularization, it could also prevent the revascularized tissue from becoming fully functional post-surgery.  On a cellular level, cardiac ischemia causes decreased energy production and cardiomyocyte death.  Evidence indicates that chronic ischemia causes down-regulation of the mitochondrial proteome(5), thus decreasing oxidative phosphorylation and electron transport necessary for ATP synthesis. Even after CABG, energy production in myocardium fails to return to normal levels despite restoration of blood flow. Prior research indicates hibernating myocardium is protected from necrosis despite decreased blood flow(5).  Mitochondrial proteome depression may play a role in this protection. Lab data shows increased oxidative stress post-revascularization, and so finding the cause of this increase is of great interest.   Hypoxic conditions in cell culture can mimic the effects of cardiac ischemia. Proteins involved in oxidative phosphorylation and ATP synthesis can be measured to observe hypoxic effects. Biochemical changes resulting from cardiac ischemia can increase production of various compounds including prostaglandin E2 (PGE2).  We have identified PGE2 as having significantly higher concentrations in revascularized myocardium, suggesting that PGE2 could play a role in continued downregulation of mitochondrial complexes.  PGE2 is a lipid derived compound that functions to dilate coronary-vascular smooth muscle while promoting platelet formation(6).  PGE2 is released under stress conditions such as cardiac ischemia, and previous research has indicated that PGE2 may be a potential mediator of damage due to myocardial infarction(6). In contrast, PGE2 has been shown to promote cardiomyocyte survival under hypertrophic conditions(7).    As PGE2 is increased in revascularized tissue and recovery of mitochondrial energetics is often not complete, we hypothesize that treatment of immortalized rat H9c2 cardiomyocytes with PGE2 may play a role in downregulation of mitochondrial protein complexes.   
 
Materials 
 DMEM, Fetal Bovine Serum, 0.05% Trypsin-EDTA (Life Tech Industries), sterile 10cm plates, Bovine Serum Albumin (BSA), Mitosciences Ox-Phos Rodent WB Antibody Cocktail (MitoScience), Goat Polyclonal IgG (Santa Cruz Biotech), TGX Precast Gels (4-20% gradient), Chemiluminescent substrate (1:1 Luminol, Stable Peroxide Solution from Thermo Scientific) 
 
Methods 
 
Surgical Procedures.  Two female Yorkshire pigs were anesthetized and underwent a thoracotomy.  A c-shaped constrictor was placed on the LAD as previously described (Kelly et al, 2011).  The wound was closed and the animal was allowed to recover and grow into the constrictor for 12 weeks.  After 12 weeks, animals were anesthetized and underwent a sternotomy. The left internal mammary artery (LIMA) was dissected and grafted to the LAD artery proximal to the constriction, allowing for restoration of blood flow to the LAD region of the left ventricle as previously described (Kelly et al, 2011).  The animal was allowed to recover and grow for an additional 4 weeks following revascularization.  Following recovery and growth after revascularization, each pig was anesthetized and underwent a sternotomy.  The heart was removed under anesthesia and heart tissue was dissected and flash frozen for future biochemical analysis. 
 
Cell Culture Immortalized rat H9c2 cardiomyocytes ordered from (ATCC)  were brought up from freeze down. Cells were transferred to 10cm culture plates and grown in DMEM +10% FBS. Once cells reached 70-90% confluence, they were incubated in 0.05% trypsin – EDTA for 5 minutes, scraped, and split 1:3 to new plates. For experiments, H9c2 cardiomyocytes were detached from 10cm plates with trypsin as described above and plated in 6-well plates at a density of 250,000 cells per well in DMEM + 10% FBS.  Cells were allowed to adhere overnight. 
 
PGE2 Treatment  Cells were treated in DMEM + 0.1% FBS (phenol-red free dye) with varying concentrations of PGE2 (0, 10nM, 100nM, or 1uM) for 24 hours. Media was harvested and frozen; cells were scraped in 100uL of RIPA buffer with Halt protease inhibitor (pierce). 
 
Protein Analysis Lysates were analyzed by Western blotting.  15uL of cell lysate was loaded in each well of a tris/glycine polyacrylamide 4-20% gradient gel and run for 1h at 180V.  Proteins were transferred to PVDF membrane overnight at 15V.  Membranes were blocked for 1h using TBS-T + milk, then incubated with 6ug/mL mitosciences OxPhos antibody mixture.  Bands were visualized using chemiluminescence and transfer to film.  Membranes were stripped and blotted for prohibitin using 1ug/mL anti-prohibitin primary antibody.  Bands were quantified by densitometry with prohibitin serving as a mitochondrial loading control.  
Quantitation of Glutathionylated Lipid Aldehydes. 
 Glutathionylated lipid aldehydes and prostaglandins were analyzed via HPLS-MS/MS as previously described(6).  100 mg of heart tissue was homogenized in 100mM sodium acetate buffer, pH 3.9 containing 50uM butylated hydroxytoluene and 500uM diethyletetriaminepentaacetic acid.  Homogenates were centrifuged at 10000g for 10 minutes and the aqueous phase removed to Strata-X columns.  Columns were washed with water and analytes eluted with methanol.  Samples were dried and analyzed by LC-MS/MS using multiple reaction monitoring and stable isotope dilution.  
 
Results 
 
Prostaglandin E2 in Hibernating Myocardium 
with CABG. Swine tissue taken from the revascularized LAD region exhibited higher levels of PGE2 than tissue taken from remote cardiac region (Fig. 1).   
PGE2 Downregulates Mitochondrial Electron 
Transport Chain Proteins.  Western blotting revealed mitochondrial protein complex I abundance decreased as the treatment concentration of PGE2 increased. (Fig. 2).  Treatment with higher concentration of PGE2 correlates to a decrease in mitochondrial protein complex I.  
 Mitochondrial complex II abundance decreased as well, although with greater variance between sample treatments. Samples treated with 1uM PGE2 exhibited the greatest drop in complex II abundance, closely followed by 10nM treatment (Fig. 3). Treatment of cells with 100nM PGE2 lead to little change in complex II abundance compared to control.   Treatment with PGE2 increased glutathionylated aldehydes in a dose-dependent manner (Fig. 3). In the 10nM and 100nM treatments, GS-DHN was slightly elevated compared to control. 1uM PGE2 had significantly higher GS-DHN levels than control.   GS-ONE levels varied with PGE2 concentrations. The 10nM treatment produced less GS-ONE than control, while the 100nM exhibited significantly higher GS-ONE concentration. 1uM PGE2-treated samples had approximately the same level of GS-ONE as control.   Samples treated with 10nM PGE2 saw a slight increase in GS-HNE compared to control, while 100nM dose was close to control. Treatment with 1uM PGE2 saw a statistically significant drop in GS-HNE production.  
  
 
 Figure 1.  Revascularization of hibernating 
myocardium results in increased prostaglandins E2 
and D2 in the LAD region as compared to remote 
region. 
  
 Figure 3.  PGE2 treatment resulted in decreased Complex I (A,B) and Complex II (A,C) protein expression.  All proteins were normalized to prohibitin. 
Complex I
Complex II
Prohibitin
A. 
B. C
  
Discussion  Onset and progression of heart disease correlates with myocardial oxidative stress and inflammation. Chronic ischemia results in reduced energetics in cardiomyocytes(5). Despite revascularization via CABG, energy levels in myocardium are still depressed. PGE2 is a pro-inflammatory lipid that has been identified as potentially contributing to energy depression in order to mitigate necrosis in cardiomyocytes under ischemic conditions(7).   Prior research by Chu et al, 2012, involving an ameroid constrictor placed on the circumflex artery of swine for three weeks to induce chronic myocardial ischemia, suggests that prostaglandins may play an important role in onset and progression of myocardial changes in response to ischemia (10). Cyclooxygenases (COX) catalyze conversion of arachidonic acids to prostaglandins such as PGE2(11).  Treatment of swine fitted with an ameroid constrictor with non-specific COX inhibitors as well as COX-2 inhibitors resulted in mitigation of physiological dysfunction.  In our model of revascularization of hibernating myocardium, PGE2 is increased in the LAD (chronically ischemic) region of myocardium as compared to the remote region(5), suggesting that inflammation is increased following restoration of blood flow.  This result, in the context of the study by Chu et al, suggests that PGE2 may play an important role in continued depression of the mitochondrial proteome and physiological dysfunction following CABG.    As a method to test the potential mechanistic validity of PGE2 with regard to depression of the mitochondrial proteome and induction of oxidative stress, we treated immortalized rat left ventricular cardiomyocytes with PGE2.   Our results indicate that PGE2 treatment downregulates mitochondrial electron transport chain complexes(9) as well as induces oxidative stress as determined by increased glutathionylated lipid aldehydes(8).  This downregulation of electron transport chain proteins may account for continued decreases in energetics and physiological function despite successful revascularization of hibernating myocardium.       
 
 
   
 
   
 
   
 
Fig. 3. GS-DHN levels exhibit slight increase from control, with 1uM PGE2 treatment having 
significant increase. GS-ONE levels vary; 10nM samples show decrease in GS-ONE while 100nM 
samples are significantly higher than control. In the 1uM treatments levels are similar to control. GS-
HNE appears to decrease when samples were treated with higher concentrations of PGE2. Treatment 
with 1uM PGE2 results in significantly lower GS-HNE production.  
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